Literature DB >> 8328500

Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly.

F I Martin1, B W Tress, P G Colman, D R Deam.   

Abstract

PURPOSE: To identify the number of cases of hyperthyroidism that followed the performance of contrast radiography in elderly patients at a geriatric hospital in a non-iodine-deficient area and to determine the clinical course of the condition. PATIENTS AND METHODS: All patients over a 20-month period with biochemical hyperthyroidism (plasma free thyroxine level greater than 25.0 pmol/L and thyroid-stimulating hormone level less than 0.10 IU/L) were identified. Clinical features of hyperthyroidism and exposure to nonionic contrast media radiographs within the previous 12 months were sought. Follow-up extended from 6 to 22 months.
RESULTS: A total of 28 patients with hyperthyroidism (aged 70 to 96 years) were identified. Seven patients (25%) had documented biochemical development of hyperthyroidism (five) or subsequent hyperthyroidism (two) 3 to 8 weeks after nonionic contrast media radiography. The four patients who underwent scanning had a multinodular thyroid, and thyroid antibodies were not detected in five of five patients. Although the condition appeared self-limited and six of six patients were euthyroid after 18 months, the condition was not benign; progress and recovery were adversely affected by hyperthyroidism. Four patients had a good response to treatment with an antithyroid drug (carbimazole).
CONCLUSION: Iodine-induced thyrotoxicosis following contrast radiography was found in 7 of 28 cases of hyperthyroidism seen at a geriatric hospital. Although the condition appears ultimately self-limited, pharmacologic control of severe clinical features may be required. The frequency of this condition in a non-iodine-deficient area appears related to the more common occurrence of autonomous thyroid nodules in the elderly. Because performance of contrast radiography is more common in this age group, the recognition and treatment of iodine-induced thyrotoxicosis are of increasing clinical importance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328500     DOI: 10.1016/0002-9343(93)90235-h

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  22 in total

Review 1.  The use of perchlorate for the prevention of thyrotoxicosis in patients given iodine rich contrast agents.

Authors:  J E Lawrence; S H Lamm; L E Braverman
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

2.  Clinical problem-solving. A hidden solution.

Authors:  Pornpoj Pramyothin; Angela M Leung; Elizabeth N Pearce; Alan O Malabanan; Lewis E Braverman
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

Review 3.  Iodine-induced thyroid dysfunction.

Authors:  Angela M Leung; Lewis E Braverman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-10       Impact factor: 3.243

4.  Thyrotoxicosis: an under-recognised aetiology.

Authors:  Anjalee Dave; Jason Ludlow; John Malaty
Journal:  BMJ Case Rep       Date:  2015-05-20

5.  Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea.

Authors:  Karsten Müssig; Claus Thamer; Roland Bares; Hans-Peter Lipp; Hans-Ulrich Häring; Baptist Gallwitz
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

6.  Contrast induced hyperthyroidism due to iodine excess.

Authors:  Usman Mushtaq; Timothy Price; Narsing Laddipeerla; Amanda Townsend; Vy Broadbridge
Journal:  BMJ Case Rep       Date:  2009-11-04

7.  Urinary iodine excretion and serum thyroid function in adults after iodinated contrast administration.

Authors:  Sun Y Lee; Donny L F Chang; Xuemei He; Elizabeth N Pearce; Lewis E Braverman; Angela M Leung
Journal:  Thyroid       Date:  2015-03-23       Impact factor: 6.568

Review 8.  A lump in the chest. A common problem in an unusual setting.

Authors:  V Patel; J J Mukherjee
Journal:  BMJ       Date:  1995-12-02

9.  Contrast Induced Thyrotoxicosis in a Patient with New onset Atrial Fibrillation: A Case Report and Review.

Authors:  Jeffrey Adler; Dustin J Colegrove
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 10.  Drug-induced thyroid disorders.

Authors:  N J Gittoes; J A Franklyn
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.